Pharmaceutical compositions against several herpes virus infections and/or atherosclerotic plaque
AssigneeBio-Virus Research Incorporated
InventorsDaniel Golubev, Alexander Chaihorsky
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition is disclosed for the treatment against several herpes virus infections or atherosclerotic plaques in a mammalian subject suspectible thereto which comprises: (a) 10 to 30% by weight of the peptide of SEQ ID 2; (b) 10 to 30% by weight of the peptide of SEQ ID 4; 10 to 30% by weight of the peptide of SEQ ID 6; and (d) 10 to 30% by weight of the peptide of SEQ ID 8; in combination with a pharmaceutically acceptable inert carrier.
Claims3
A composition for generating an immune response to a herpes infection which consists essentially of:
- (a) 10 to 30% of a peptide having Sequence ID 2;
- (b) 10 to 30% of a peptide having Sequence ID 4;
- (c) 10 to 30% of a peptide having Sequence ID 6;
- and
- (d) 10 to 30% of a peptide having Sequence ID 8 all in combination with a pharmaceutically acceptable inert carrier.
A method of generating an immune response to a herpes infection which comprises the step of administering to a mammalian subject an effective amount of a composition consisting essentially of:
- (a) 10 to 30% of a peptide having Sequence ID 2;
- (b) 10 to 30% of a peptide having Sequence ID 4;
- (c) 10 to 30% of a peptide having Sequence ID 6;
- and
- (d) 10 to 30% of a peptide having Sequence ID 8.
Dependencies are inferred from the claim text.